December 11, 2014
The Journal of Human Hypertension, a British medical journal , has retracted a sub-analysis paper of the VART study, one of Novartis Pharma’s hypertension drug Diovan (valsartan) studies conducted by Chiba University, it has been revealed recently. According to the...read more